105 related articles for article (PubMed ID: 25461907)
1. Ursodeoxycholic acid alleviates cholestasis-induced histophysiological alterations in the male reproductive system of bile duct-ligated rats.
Saad RA; Mahmoud YI
Reprod Toxicol; 2014 Dec; 50():87-97. PubMed ID: 25461907
[TBL] [Abstract][Full Text] [Related]
2. Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid.
Mahmoud YI
Life Sci; 2015 Sep; 136():52-9. PubMed ID: 26141989
[TBL] [Abstract][Full Text] [Related]
3. Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction.
Kiani S; Valizadeh B; Hormazdi B; Samadi H; Najafi T; Samini M; Dehpour AR
Eur J Pharmacol; 2009 Aug; 615(1-3):246-51. PubMed ID: 19445924
[TBL] [Abstract][Full Text] [Related]
4. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
6. Consequences of complete bile-duct ligation on the pubertal process in the male rat.
Van Thiel DH; Gavaler JS; Zajko AB; Cobb CF
J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):616-21. PubMed ID: 4032178
[TBL] [Abstract][Full Text] [Related]
7. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M
Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639
[TBL] [Abstract][Full Text] [Related]
8. Epididymal ultrastructural changes associated with chronic cholestasis after bile duct ligation in adult rats.
Mahmoud YI; Abo-Zeid FS
Ultrastruct Pathol; 2018; 42(4):344-349. PubMed ID: 29952690
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
11. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of resveratrol against oxidative stress in cholestasis.
Ara C; Kirimlioglu H; Karabulut AB; Coban S; Ay S; Harputluoglu M; Kirimlioglu V; Yilmaz S
J Surg Res; 2005 Aug; 127(2):112-7. PubMed ID: 16083749
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
14. Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats.
Han JM; Kim HG; Choi MK; Lee JS; Lee JS; Wang JH; Park HJ; Son SW; Hwang SY; Son CG
Exp Toxicol Pathol; 2013 Sep; 65(6):837-44. PubMed ID: 23298556
[TBL] [Abstract][Full Text] [Related]
15. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
Ebrahimi F; Tavakoli S; Hajrasouliha AR; Shafaroodi H; Sadeghipour H; Riazi K; Borhani AA; Houshmand G; Ahmadi SH; Dehpour AR
Eur J Pharmacol; 2005 Oct; 523(1-3):93-100. PubMed ID: 16226248
[TBL] [Abstract][Full Text] [Related]
16. Cholestasis-associated reproductive toxicity in male and female rats: The fundamental role of mitochondrial impairment and oxidative stress.
Ommati MM; Farshad O; Niknahad H; Arabnezhad MR; Azarpira N; Mohammadi HR; Haghnegahdar M; Mousavi K; Akrami S; Jamshidzadeh A; Heidari R
Toxicol Lett; 2019 Nov; 316():60-72. PubMed ID: 31520699
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat.
Jacquemin E; Dumont M; Mallet A; Erlinger S
Eur J Clin Invest; 1993 Dec; 23(12):794-802. PubMed ID: 8143756
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of resveratrol against renal oxidative stress in cholestasis.
Ara C; Karabulut AB; Kirimlioglu H; Coban S; Ugras M; Kirimliglu V; Yilmaz S
Ren Fail; 2005; 27(4):435-40. PubMed ID: 16060133
[TBL] [Abstract][Full Text] [Related]
19. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]